Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Definitive Healthcare (DH) over the last 5 years, with Q3 2025 value amounting to $107.8 million.

  • Definitive Healthcare's Shares Outstanding (Diluted Average) fell 804.27% to $107.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.8 million, marking a year-over-year decrease of 804.27%. This contributed to the annual value of $116.6 million for FY2024, which is 343.69% up from last year.
  • Latest data reveals that Definitive Healthcare reported Shares Outstanding (Diluted Average) of $107.8 million as of Q3 2025, which was down 804.27% from $109.8 million recorded in Q2 2025.
  • Over the past 5 years, Definitive Healthcare's Shares Outstanding (Diluted Average) peaked at $117.8 million during Q2 2024, and registered a low of $88.3 million during Q3 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $109.8 million (2025), whereas its average is $107.5 million.
  • As far as peak fluctuations go, Definitive Healthcare's Shares Outstanding (Diluted Average) soared by 1658.81% in 2022, and later crashed by 804.27% in 2025.
  • Quarter analysis of 5 years shows Definitive Healthcare's Shares Outstanding (Diluted Average) stood at $91.9 million in 2021, then rose by 10.01% to $101.1 million in 2022, then grew by 11.52% to $112.8 million in 2023, then grew by 3.44% to $116.6 million in 2024, then fell by 7.61% to $107.8 million in 2025.
  • Its last three reported values are $107.8 million in Q3 2025, $109.8 million for Q2 2025, and $112.8 million during Q1 2025.